Latest Blog Posts Tagged "Missouri"
June 13, 2016
Today the Foundation announced a $2 million prize to motivate the research field to develop an imaging tracer to visualize alpha-synuclein in the brain and help test therapies to slow or stop disease.
March 23, 2015
Pharmaceutical company Biogen last week shared positive results from its study of a drug to slow Alzheimer's progression. These findings have implications for Parkinson's research, as well.
September 04, 2014
David Eidelberg, MD, talked to us about his recently published research into mapping response to sham (placebo) surgery and how his findings may help research move faster.
December 31, 2013
Dr. Kathleen Shannon of Rush University talks to Dave Iverson about the need for a definitive Parkinson's diagnostic test, what researchers are doing to develop one and how patients can help.
December 30, 2013
The University of Minnesota's Center for Magnetic Resonance Research (CMRR) recently acquired the first 10.5 Tesla whole-body magnetic resonance imaging (MRI) magnet.
November 20, 2013
Every research project we fund is a step closer to new and better therapies for people with Parkinson's disease. Read about three exciting, newly funded grants.
November 08, 2013
Levels of alpha-synuclein in the brainmeasured through imaging toolscould be a biomarker that would help researchers diagnose the disease better and test potential therapies faster.
October 07, 2013
A recent report on dopamine neuron activity in Parkinson's disease (PD) patients emphasizes the need for biomarkers for earlier detection.
July 23, 2013
Our June 27 Webinar, a "Biomarkers Update" as part of our Hot Topics in Parkinson's Disease (PD) Research Seminar Series, featured Ken Marek and Mark Frasier, moderated by Dave Iverson.